"I'm taking some shorts that haven’t been working off our Investing Ideas list with SPY at the low-end of the @Hedgeye Risk Range," writes CEO Keith McCullough.
***No change to Healthcare analyst Tom Tobin's fundamental short thesis on the company. Click here to read our analyst's original report.
